SAM
NUVB icon

Shell Asset Management’s Nuvation Bio NUVB Stock Holding History

Shell Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$39K Sell
10,592
-15,545
-59% -$42.4K ﹤0.01% 939
2025
Q2 		$51K Sell
26,137
-2,748
-10% -$5.72K ﹤0.01% 1142
2025
Q1 		$51K Sell
28,885
-1,202
-4% -$2.74K ﹤0.01% 1143
2024
Q4 		$80K Hold
30,087
– – ﹤0.01% 1088
2024
Q3 		$69K Buy
+30,087
New +$91.8K ﹤0.01% 1129
2024
Q1 		$90K Buy
+30,651
New +$58.9K ﹤0.01% 1048
2022
Q2 		– Sell
-5,870
Closed -$31K – 1422
2022
Q1 		$31K Sell
5,870
-866
-13% -$4.87K ﹤0.01% 1364
2021
Q4 		$57K Sell
6,736
-104
-2% -$956 ﹤0.01% 1362
2021
Q3 		$68K Sell
6,840
-250
-4% -$2.27K ﹤0.01% 1344
2021
Q2 		$66K Buy
+7,090
New +$80.8K ﹤0.01% 1412

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Shell Asset Management's NUVB Position: Q3 2025 in Review

Shell Asset Management reduced its Nuvation Bio (NUVB) stake by 59% in Q3 2025, selling an estimated $42.4K and leaving 10,592 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #939.

Shell Asset Management first reported a position in NUVB in Q2 2021 and has held it in 10 quarters since. The position peaked at $90K in Q1 2024. 203 funds tracked by Wall St. Rank hold NUVB as of Q3 2025.

  • Shell Asset Management held 10,592 shares of Nuvation Bio worth $39K as of Q3 2025.
  • Shell Asset Management sold 15,545 Nuvation Bio shares in Q3 2025, an estimated $42.4K.
  • Nuvation Bio made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #939 holding.
  • Shell Asset Management first reported a position in Nuvation Bio in Q2 2021 and has held it in 10 quarters since.
  • Shell Asset Management's Nuvation Bio position peaked at $90K in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.